Prodia prices IPO to sell on Trump effect

The diagnostics company takes a realistic approach to pricing as foreign investors turn net sellers across Southeast Asia.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES